http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.
Okonechnikov, K. (First author)DKFZ* ; Ghasemi, D. R.DKFZ* ; Schrimpf, D.DKFZ* ; Tonn, S. ; Mynarek, M. ; Koster, J. ; Milde, T.DKFZ* ; Zheng, T.DKFZ* ; Sievers, P.DKFZ* ; Sahm, F.DKFZ* ; Jones, D. T. W.DKFZ* ; Deimling, A. v.DKFZ* ; Pfister, S. M.DKFZ* ; Kool, M.DKFZ* ; Pajtler, K. W.DKFZ* ; Korshunov, A. (Last author)DKFZ*
2025
Biomed Central
London
This record in other databases: 
Please use a persistent id in citations: doi:10.1186/s40478-025-02094-w
Note: #EA:B062#LA:B300#
Contributing Institute(s):
- B062 Pädiatrische Neuroonkologie (B062)
- DKTK HD zentral (HD01)
- KKE Neuropathologie (B300)
- KKE Pädiatrische Onkologie (B310)
- Pädiatrische Gliomforschung (B360)
Research Program(s):
- 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)
Appears in the scientific report
2025
Database coverage:
;

; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection